scholarly article | Q13442814 |
P356 | DOI | 10.1093/JNCI/DJJ137 |
P698 | PubMed publication ID | 16622127 |
P50 | author | Patrice Dubreuil | Q30089953 |
Jean Robert Delpero | Q59677704 | ||
P2093 | author name string | Ying Yang | |
Jocelyne Jacquemier | |||
Hagay Sobol | |||
Anthony Gonçalves | |||
Francois Bertucci | |||
Tetsuro Noguchi | |||
Genevieve Monges | |||
Donatella Di Stefano | |||
Fabienne Palmerini | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | imatinib | Q177094 |
P304 | page(s) | 562-563 | |
P577 | publication date | 2006-04-01 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis | |
P478 | volume | 98 |
Q33737479 | A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis |
Q37045567 | AKT1 and BRAF mutations in pediatric aggressive fibromatosis |
Q42908309 | Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects |
Q38656475 | High-grade soft tissue sarcoma arising in a desmoid tumor: case report and review of the literature |
Q34129408 | Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis |
Q34168680 | Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology |
Q35820278 | KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome |
Q47157396 | Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach: A case report |
Q38736110 | Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies |
Q35842446 | Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations |
Q36264188 | Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions. |
Search more.